Saakshi Medtech & Panels Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Expect revenue growth starting from H1 FY26, following deferred orders and operational normalization.
- New facility operational by April-May 2025, doubling existing capacity utilization and enabling growth.
- Anticipate around 20% revenue growth impact in the current financial year.
- Growth driven by diversified sectors: electrical panels, fabrication (radiators, railways), medical, and data centers.
- Orders from key customers (e.g., GE, Rolls-Royce, Siemens, L&T) expected to ramp up.
- Wind turbine generator (WTG) business to contribute significantly with 5.5 MW and 3.3 MW projects approved, projecting INR10-20 crores orders.
- Export sales showing 40% year-on-year growth, increasing export share to over 5%.
- Expansion into complete package solutions and fabrication expected to attract more business.
- New dedicated wind factory to focus on new developments, contributing to multiple-fold increase in GE-related revenue.
See what Saakshi Medtech & Panels Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The transcript and presentation excerpts do not indicate any current or planned fundraising through debt or equity.
- Company emphasizes strengthening of the balance sheet with a 31.26% decrease in long-term borrowings, showing a focus on reducing debt.
- Capital expenditure is being funded internally, with INR407.84 lakh allocated to capital work in progress for infrastructure and manufacturing capacity.
- No mention or discussion of any new debt or equity issuance plans during the call or in the presentation.
- Management mentions prudent retained earnings management to increase shareholder funds, implying organic growth rather than reliance on external fundraising.
See what Saakshi Medtech & Panels Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Current capital work in progress (Capex) is INR 407.84 lakhs, focused on infrastructure and manufacturing capacity to meet future demand.
- Key ongoing capital project: New manufacturing facility expected to be fully operational by April-May 2025, aimed at replacing a rented facility and doubling existing production capacity.
- Strategic focus on expanding production with potential to add second and third shifts to increase capacity utilization.
- Investments in intangible assets amounting to INR 103.6 lakhs enhancing technology upgrades and product innovation.
- Plans to ramp up production capabilities to support growth in wind turbine control systems, fabrication, and electrical panels segments.
- Emphasis on strengthening balance sheet by reducing long-term borrowings by 31.26%, supporting financial stability for future investments.
Track Saakshi Medtech & Panels Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Revenue growth expected to resume from H1 FY26 after temporary setbacks in FY25.
- FY25 revenues projected to be under pressure, possibly lower than FY24's INR121 crores.
- Operating efficiencies and cost management efforts have been strong, supporting profitability.
- New facility (operational from Q2 FY25) to double capacity utilization, enabling future growth.
- Expansion into fabrication and electrical panels across sectors (wind turbines, data centers, defense) expected to boost revenues.
- New wind turbine products (5.5 MW and 3.3 MW prototypes) anticipated to contribute INR10-20 crores annually.
- Export sales have shown 40% growth year-over-year and now constitute over 5% of total sales, indicating incremental gains.
- Earnings per share declined in H1 FY25 but expected to improve with resumed growth.
- Margin improvements supported by reduction in finance cost (>74%) and strict cost control.
- Long-term growth seen as strong with product and customer diversification initiatives underway.
Order book
- The company has received a new significant order from Mahindra and Mahindra Finance (exact financial details restricted).
- There is an order worth approximately INR 2 crores pending execution for the defense business.
- A large order involving around 44 radiators and 44 DG sets for the data center business will start realizing from January 2025.
- Prototype orders for wind turbine generators (WTG) include 23 sets for 5.5 MW turbines (~INR 10 crores order book) and 2 prototype units for 3.3 MW turbines, with expected future orders around INR 20 crores.
- Some orders from key customers have been deferred due to operational delays but are not cancelled; these are expected to resume by mid-2025.
- The company is actively expanding its order book through new development projects, particularly in fabrication and electrical panels for diverse sectors like wind turbines, medical, defense, and data centers.
How does Saakshi Medtech & Panels Ltd rank vs peers in Electrical Equipment?
Pro featureHow does Saakshi Medtech & Panels Ltd rank in Electrical Equipment?
Compare Saakshi Medtech & Panels Ltd against every Electrical Equipment company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Saakshi Medtech & Panels Ltd's management said in earlier quarters
Others in Electrical Equipment this season
- Bajel Projects (Q4 FY26)
The current order book stands slightly below INR3,500 crores, with new orders worth over INR1,000 crores secured in early FY27. Key concall takeaways from…
- Diamond Power (Q1 FY27)
As of August 11, 2026, the order book stands at INR 3,688 crores (~$445 million), about twice last year’s revenue. Key concall takeaways from Diamond Power…
- Supreme Power (Q1 FY27)
By FY29, revenue could grow to between INR550 crores to INR600 crores. Key concall takeaways from Supreme Power Equipment Ltd's Q1 FY27 earnings call — and how…
- Solex Energy (Q1 FY27)
Current order book stands at approximately INR 3,400 crore. Key concall takeaways from Solex Energy Ltd's Q1 FY27 earnings call — and how it ranks against…